BETA
This is a BETA experience. You may opt-out by clicking here

More From Forbes

Edit Story

Can You Make A Difference And A Profit? Estee Lauder Does

This article is more than 8 years old.

The Estée Lauder Companies, working through its MAC's VIVA GLAM Lipstick, has become one of the leading funders in the fight against HIV/AIDS around the world, donating over $350 million total over 20 years reaching over $40 million per year recently.

Nancy Mahon, Senior Vice President, Global Philanthropy and Corporate Citizenship, explains the company's passion for working so diligently to end AIDS, "We can only end AIDS if we test and treat everyone at risk of and actually infected with HIV. As only half of the people in the world who need HIV testing and treatment can get it, and funding for the epidemic is declining... we desperately need corporation's business acumen and resources -- including the ability to market and sell ideas -- to tackle the world's biggest problems, including ending AIDS."

"The people behind many corporations are incredibly skilled at defining and efficiently solving many of the key business and resourcing issues, which also stand in the way of issues like equitable access to medical care.," she continues.

"While science has now made it possible to end AIDS, it’ll only become a reality if we get a realistic and achievable business plan in place," she concludes.

On Friday, July 10, 2015 at 1:00 Eastern, Mahon will return to my show here to talk about measuring return on investment for The Estée Lauder Companies in leading the fight against AIDS. Tune in here then to watch the interview live. Post questions in the comments below or tweet questions before the interview to @devindthorpe. 

You can download an audio podcast here or subscribe via iTunes.

More about The Mac AIDS Fund:

Twitter : @macaidsfund

The MAC AIDS Fund (MAF), the heart and soul of MAC Cosmetics, was established in 1994 to support men, women and children affected by HIV/AIDS globally. MAF is a pioneer in HIV/AIDS funding, providing financial support to organizations working with underserved regions and populations. Recently recognized by Funders Concerned About AIDS as the top corporate giver in the arena, MAF is committed to addressing the link between poverty and HIV/AIDS by supporting diverse organizations around the world that provide a wide range of services to people living with HIV/AIDS. To date, MAF has raised more than $340 million (U.S.) exclusively through the sale of MAC’s VIVA GLAM Lipstick and Lipglass donating 100 percent of the sale price to fight HIV/AIDS. For more information, visit www.macaidsfund.org.

Mahon's bio:

Twitter: @nancy_mahon

Nancy is Senior Vice President, Global Philanthropy and Corporate Citizenship, for The Estée Lauder Companies and Global Executive Director of the M·A·C AIDS Fund. In this role, she is responsible for Estée Lauder’s global corporate citizenship strategy, encompassing all philanthropic, cause-marketing, employee engagement, and product donation programs. Nancy also oversees the strategic direction and day- to-day operation of the M·A·C AIDS Fund. Currently, the Fund gives away $44 million annually throughout the world, particularly in the 72 countries in which M·A·C has affiliates.

In December 2011, Nancy was appointed as the Chair of the Presidential Advisory Council on HIV/AIDS (PACHA). PACHA provides advice and recommendations to the President and the Secretary of Health and Human Services on programs and policies intended to promote effective prevention of HIV disease, and to advance research on HIV disease and AIDS.

Prior to joining M·A·C in June 2006, Nancy was Executive Director of God’s Love We Deliver (GLWD), the nation’s oldest and largest provider of life-sustaining nutritional support services for people living with HIV/AIDS, cancer and other serious illnesses.

Nancy is a magna cum laude graduate of Yale University and New York University’s School of Law, where she was an editor of the Law Review. She and her partner reside in New York City with their two children.